XML 26 R46.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Tables)
 12 Months Ended
Dec. 31, 2011
Segment Information [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
The table below presents information about the segments as of and for the years ended December 31, 2011, 2010 and 2009 (in thousands):

 
 
For the years ended December 31,
2011:
 
LTC
 
SCG
 
Corporate/Other
 
Consolidated
Totals
Net sales
 
$
5,123,477

 
$
1,044,191

 
$
15,254

 
$
6,182,922

Depreciation and amortization expense
 
(64,484
)
 
(16,221
)
 
(52,427
)
 
(133,132
)
Settlement, litigation and other related charges
 
(55,031
)
 
(643
)
 
—

 
(55,674
)
Other miscellaneous charges, net
 
(15,049
)
 
—

 
(1,044
)
 
(16,093
)
Operating income (loss) from continuing operations
 
476,800

 
98,938

 
(142,795
)
 
432,943

2010:
 
 

 
 

 
 

 
 

Net sales
 
$
5,175,730

 
$
838,790

 
$
16,150

 
$
6,030,670

Depreciation and amortization expense
 
(58,271
)
 
(17,094
)
 
(75,181
)
 
(150,546
)
Settlement, litigation and other related charges
 
(113,279
)
 
(430
)
 
—

 
(113,709
)
Other miscellaneous charges, net
 
(13,745
)
 
(14,173
)
 
(119,313
)
 
(147,231
)
Operating income (loss) from continuing operations
 
374,110

 
75,039

 
(259,995
)
 
189,154

2009:
 
 

 
 

 
 

 
 

Net sales
 
$
5,271,388

 
$
712,768

 
$
16,897

 
$
6,001,053

Depreciation and amortization expense
 
(71,389
)
 
(18,461
)
 
(47,832
)
 
(137,682
)
Settlement, litigation and other related charges
 
(77,449
)
 
—

 
—

 
(77,449
)
Other miscellaneous charges, net
 
(16,281
)
 
(163
)
 
(9,263
)
 
(25,707
)
Operating income (loss) from continuing operations
 
530,600

 
87,972

 
(148,821
)
 
469,751


The Company's operations are primarily in the United States with one pharmacy located in Canada which is not material to the consolidated sales or total assets of Omnicare.